Written by Private MD Labs Medical Writing Team ⢠Last Updated: September 8, 2025
Amyloidosis is a rare disease characterized by the abnormal accumulation of amyloid proteins in tissues and organs throughout the body. While definitive diagnosis often requires tissue biopsy, specialized blood and urine tests play a crucial role in detecting the presence of abnormal proteins and supporting the diagnostic process.
This test measures free light chains and their ratio in the blood. An abnormal kappa/lambda ratio can indicate amyloidosis, as amyloid proteins are often produced when the body breaks down antibodies containing these light chains.
Laboratory tests are fundamental in identifying the abnormal proteins that characterize amyloidosis. These tests can detect monoclonal proteins, abnormal light chains, and other protein abnormalities in blood and urine that may indicate the presence of amyloid deposits. Early detection through laboratory testing is essential for proper treatment and monitoring.
This urine test detects abnormal proteins that may be present in amyloidosis. The presence of abnormal proteins in urine identified through immunofixation can provide important evidence supporting an amyloidosis diagnosis.
This blood test can detect the presence of abnormal amyloid proteins in the serum. It is a key diagnostic tool for identifying the specific type of abnormal protein that may be causing amyloidosis.
This test separates and analyzes different proteins in the blood, helping to identify the abnormal amyloid proteins that characterize this rare disease. It provides a pattern analysis that can reveal protein abnormalities.
Amyloidosis can lead to increased levels of Beta-2 Microglobulin in the blood. This test helps assess the extent of protein deposition and can be used for monitoring disease progression.
This comprehensive test analyzes protein patterns in the blood and automatically performs immunofixation if abnormalities are detected. It can identify the abnormal protein patterns characteristic of amyloidosis and detect abnormal amyloid proteins in the bloodstream.
This test detects abnormal light chains that can form part of the amyloid protein deposits. Since abnormal light chains are a key component of certain types of amyloidosis, this test is valuable for diagnosis and monitoring.
This combined test analyzes both protein patterns and light chain levels. Abnormal protein bands detected through this comprehensive analysis may indicate amyloidosis, helping to identify the characteristic protein abnormalities of this rare disease.
Amyloidosis testing involves complex protein analysis that requires expert interpretation. Abnormal results may indicate the presence of amyloid proteins, but definitive diagnosis typically requires additional testing and clinical correlation. Your healthcare provider will evaluate these results in the context of your symptoms and may recommend additional diagnostic procedures.
The information provided here is for educational purposes only and is not a substitute for professional medical advice. Amyloidosis is a complex condition that requires specialized medical care. Always consult with a healthcare provider for proper diagnosis, treatment, and monitoring.